RHT — Resonance Health Balance Sheet
0.000.00%
Last trade - 00:00- AU$23.92m
- AU$24.74m
- AU$11.16m
- 45
- 45
- 37
- 37
Annual balance sheet for Resonance Health, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 8.86 | 6.78 | 6.36 | 6.85 | 2.98 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.79 | 1.51 | 1.14 | 2.32 | 3.52 |
| Prepaid Expenses | |||||
| Total Current Assets | 9.69 | 8.35 | 7.56 | 9.29 | 6.61 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.108 | 0.391 | 0.63 | 1.01 | 1.57 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 12.4 | 11.7 | 11 | 20.3 | 17.9 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.612 | 0.807 | 0.875 | 6.15 | 5.18 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.612 | 0.996 | 1.05 | 9.35 | 8.5 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 11.8 | 10.7 | 9.94 | 10.9 | 9.39 |
| Total Liabilities & Shareholders' Equity | 12.4 | 11.7 | 11 | 20.3 | 17.9 |
| Total Common Shares Outstanding |